1 year return (CAGR)
-11.11%
Acrivon Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
ACRV
1.76
-0.03 (-1.68%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-31.27%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
75.42M
Price/Sales
-
Ent value
46.43M
Price/Book
0.87
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.79 |
| Daily high | 1.85 |
| Daily low | 1.71 |
| Daily Volume | 111K |
| All-time high | 23.20 |
| 1y analyst estimate | 11.50 |
| Beta | 1.93 |
| EPS (TTM) | -1.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ACRV | S&P500 | |
| Current price drop from All-time high | -92.41% | -1.25% |
| Highest price drop | -95.47% | -56.47% |
| Date of highest drop | 30 May 2025 | 9 Mar 2009 |
| Avg drop from high | -72.59% | -10.65% |
| Avg time to new high | 110 days | 12 days |
| Max time to new high | 931 days | 1805 days |
News
